Finance

Lists
BSLN:SWX
Basilea Pharmaceutica AG Allschwil
CHF 64.50
-1.38%
(-0.90) 1D
Aug 28, 5:30:23 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for BSLN...
Open
CHF 65.40
High
CHF 66.00
Low
CHF 64.50
Mkt. cap
865.93M
Avg. vol.
47.41K
Volume
29.17K
P/E ratio
16.84
52-wk high
CHF 66.50
52-wk low
CHF 44.70
EPS
CHF 3.83
Shares outstanding
13.43M
No. of employees
200
Open
CHF 65.40
High
CHF 66.00
Low
CHF 64.50
Mkt. cap
865.93M
Avg. vol.
47.41K
Volume
29.17K
P/E ratio
16.84
52-wk high
CHF 66.50
52-wk low
CHF 44.70
EPS
CHF 3.83
Shares outstanding
13.43M
No. of employees
200
Profile
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
About Basilea Pharmaceutica AG Allschwil
CEODavid Veitch
Employees200
Founded2000
Headquarters-
SectorBiotechnology
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
64.21M
64.21M
59.50M
59.50M
Cost of goods sold
41.35M
41.35M
34.73M
34.73M
Cost of revenue
41.35M
41.35M
34.73M
34.73M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.93M
8.93M
8.77M
8.77M
Operating expense
8.93M
8.93M
8.77M
8.77M
Total operating expenses
50.28M
50.28M
43.49M
43.49M
Operating income
13.93M
13.93M
16.00M
16.00M
Other non operating income
-309.00K
-309.00K
564.00K
564.00K
EBT including unusual items
13.26M
13.26M
16.07M
16.07M
EBT excluding unusual items
13.26M
13.26M
16.17M
16.17M
Income tax expense
1.05M
1.05M
2.10M
2.10M
Effective tax rate
7.89%
7.89%
13.07%
13.07%
Other operating expenses
-
-
-
-
Net income
12.22M
12.22M
13.97M
13.97M
Net profit margin
19.03%
19.03%
23.48%
23.48%
Earnings per share
-
-
-
-
Interest and investment income
357.50K
357.50K
308.50K
308.50K
Interest expense
-716.50K
-716.50K
-704.00K
-704.00K
Net interest expenses
-359.00K
-359.00K
-395.50K
-395.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
14.91M
14.91M
16.05M
16.05M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps